Endoplasmic Reticulum Stress
7
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection
Effect of Anaesthesia on ER Stress in Cancer Patients
High GRP78 Levels in Covid-19 Infection: A Case-Control Study
Relationship Between Endoplasmic Reticulum Stress and Pain in Patients With Endometriosis
Evaluation of Endoplasmic Reticulum Stress in Patients With Recurrent Pregnancy Loss
Tauroursodeoxycholic Acid for Protease-inhibitor Associated Insulin Resistance
Role of Endoplasmic Reticulum Stress in the Pathophysiology of Type 2 Diabetes